NCT04290390View on ClinicalTrials.gov

Annovera™ Drug-Drug Interaction Study

PHASE1CompletedINTERVENTIONAL

Enrollment

67

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

January 6, 2021

Study Completion Date

January 6, 2021

Conditions

WomenContraception

Interventions

DRUG

Segesterone Acetate and Ethinyl Estradiol

Contraceptive Vaginal System

DRUG

Rifampin

CYP3A inducer

DRUG

Itraconazole

CYP3A inhibitor

Trial Locations (1)

G1P OA2

Syneos Health, Québec

Sponsors

Lead Sponsor

All Listed Sponsors

lead

TherapeuticsMD

INDUSTRY

NCT04290390 - Annovera™ Drug-Drug Interaction Study | Biotech Hunter | Biotech Hunter